Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.

Neuroreport - 26 Nov 1999

Molina L, Touchon J, Herpé M, Lefranc D, Duplan L, Cristol J P, Sabatier R, Vermersch P, Pau B, Mourton-Gilles C

Abstract excerpt

To evaluate the usefulness of tau proteins as biological markers in the diagnosis of dementia of the Alzheimer type (DAT), we analyzed the concentration of tau proteins in 253 cerebrospinal fluid (CSF) samples from patients with or without neurological disorders. Our study showed a significant increase of the mean CSF tau concentration in DAT patients compared with that from non-DAT patients. Interestingly, a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Dementia

Share to Diagnosis, Differential

Share to Down Syndrome

Share to Sex Factors

Share to tau Proteins

Source

Identifiers

PMID: 10619631
DOI: 10.1097/00001756-199911260-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.PMID 10619631Read ↗

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.Semantic proximity Read ↗

CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.Semantic proximity Read ↗

Amyloid-beta and tau proteins as biochemical markers of Alzheimer's diseaseSemantic proximity Read ↗

The Use of Proteomics in Biomarker Discovery in Neurodegenerative DiseasesSemantic proximity Read ↗

Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's disease.Semantic proximity Read ↗

Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent InsightsSemantic proximity Read ↗

CSF Total tau, Aβ42 and Phosphorylated tau Protein as Biomarkers for Alzheimer's DiseaseSemantic proximity Read ↗

CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.Semantic proximity Read ↗

[Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease].Semantic proximity Read ↗

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.Semantic proximity Read ↗

[Apolipoprotein E(ApoE)and tau protein in Alzheimer type dementia].Semantic proximity Read ↗

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.